How GSK is rebuilding its cancer business
- Posted on May 8, 2026
- By Financial Times
- 0 Views
- 1 min read
How GSK is rebuilding its cancer business
A decade after exiting oncology, the UK pharma group is betting that R&D and acquisitions will help it hit sales of £40bn